Nanoform Interim Report January - September 2021

/PRNewswire/ -- The strong momentum continues: all near-term business targets for 2021 achieved, rapid customer project intake accelerating, commercial team in...

Related Keywords

Norway ,United States ,Denmark ,Stockholm ,Sweden ,United Kingdom ,Texas ,Finland ,Helsinki ,Eteläuomen Läi ,San Diego ,California ,Finnish ,Swedish ,Celanese Vitaldose ,Christian Jones ,Nathalie Huther ,Miguel Calado ,Biologics Po ,Jeanne Thoma ,Christopher Worral ,Vp Business Development Europe ,Finnish Financial Supervisory Authority ,Boehringer Ingelheim ,Melinda Gates Foundation ,Finland Branch ,Pfizer ,Data Business Solutions ,Danske Bank ,Celanese Corporation ,Herantis Pharma Plc ,Master Services Agreement ,Vp Business Development ,Nanoform Finland Plc ,European Biotech Company ,Nacuity Pharmaceuticals ,Coast Us Biotech Company ,Biologics Proof ,Concept Agreement ,Biologics Poc ,East Coast ,Commercial Insights Officer ,Oxford United Kingdom ,European Biotech ,Development Europe ,Business Solutions ,Information Security Management System ,Active Pharmaceutical Ingredients ,Finland Plc ,Nasdaq First North Growth Market ,Certified Adviser ,Interim Report January ,Nanoform ,